YouTube bans coronavirus conspiracy videos after livestreamer falsely links virus to 5G networks
YouTube is banning conspiracy videos that spread misinformation about the coronavirus pandemic, a spokesperson for the platform told BBC.
The ban was prompted after a two-hour live stream riddled with false accusations appeared on YouTube, and was deleted only after it had concluded. Previously, the platform stated it would limit such videos in the "Up Next" section, BBC reports.
The since-deleted live-streamed interview with conspiracy theorist David Icke appeared on the platform Monday. Icke falsely promoted a growing conspiracy linking coronavirus and 5G networks, and falsely stated that coronavirus vaccines will include chips to control humans, per BBC.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The live video was watched by 65,000 people, BBC reports, with several viewers commenting in support of attacks on 5G towers. The conspiracy has been promoted by celebrities, and some towers in the U.K. were actually set on fire.
"Now any content that disputes the existence or transmission of COVID-19, as described by the [World Health Organization] and local health authorities is in violation of YouTube policies," the spokesperson told BBC.
Read more at BBC.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Taylor Watson is audience engagement editor for TheWeek.com and a former editorial assistant. She graduated from Syracuse University, with a major in magazine journalism and minors in food studies and nutrition. Taylor has previously written for Runner's World, Vice, and more.
-
What are annuities and how do they work?
The explainer They are commonly associated with retirement planning due to their ability to provide reliable payments over time
By Becca Stanek, The Week US Published
-
'Food tourism as we've known it has become a victim of its own success'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Chief justice warns against defying Supreme Court
Speed Read Supreme Court Chief Justice John Roberts noted that public officials keep threatening to ignore lawful court rulings
By Peter Weber, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published